Analysts: Northwest Biotherapeutics Inc (NWBO.OQ)

NWBO.OQ on NASDAQ Stock Exchange Capital Market

5.95USD
21 Jul 2014
Price Change (% chg)

$-0.06 (-1.00%)
Prev Close
$6.01
Open
$5.96
Day's High
$5.99
Day's Low
$5.82
Volume
86,404
Avg. Vol
253,103
52-wk High
$10.60
52-wk Low
$3.10

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.34 December 22 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 1 0.20 0.20 0.20 --
Quarter Ending Dec-14 1 0.20 0.20 0.20 --
Year Ending Dec-14 1 0.80 0.80 0.80 --
Earnings (per share)
Quarter Ending Sep-14 1 -0.34 -0.34 -0.34 --
Quarter Ending Dec-14 1 -0.32 -0.32 -0.32 --
Year Ending Dec-14 1 -1.85 -1.85 -1.85 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-14 0.90 0.00 0.90 100.00
Quarter Ending Dec-13 0.77 0.00 0.77 100.00
Quarter Ending Sep-13 0.50 0.40 0.10 20.00
Earnings (per share)
Quarter Ending Mar-14 -0.39 -0.88 0.49 -125.64
Quarter Ending Dec-13 -0.41 -0.40 0.01 -2.44
Quarter Ending Sep-13 -0.32 -0.65 0.32 -100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 0.20 0.20 0.80 0.77 --
Quarter Ending Dec-14 0.20 0.20 0.28 0.28 --
Year Ending Dec-14 0.80 0.80 2.06 2.88 --
Earnings (per share)
Quarter Ending Sep-14 -0.34 -0.34 -0.32 -0.38 --
Quarter Ending Dec-14 -0.32 -0.32 -0.32 -0.41 --
Year Ending Dec-14 -1.85 -1.85 -1.83 -1.14 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Factual Report
$150.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks